BioNote Statistics
Total Valuation
BioNote has a market cap or net worth of KRW 483.49 billion. The enterprise value is 82.01 billion.
Market Cap | 483.49B |
Enterprise Value | 82.01B |
Important Dates
The last earnings date was Friday, February 28, 2025.
Earnings Date | Feb 28, 2025 |
Ex-Dividend Date | Mar 28, 2025 |
Share Statistics
BioNote has 101.36 million shares outstanding. The number of shares has decreased by -0.01% in one year.
Current Share Class | n/a |
Shares Outstanding | 101.36M |
Shares Change (YoY) | -0.01% |
Shares Change (QoQ) | -0.02% |
Owned by Insiders (%) | 54.93% |
Owned by Institutions (%) | 0.26% |
Float | 17.71M |
Valuation Ratios
The trailing PE ratio is 8.80.
PE Ratio | 8.80 |
Forward PE | n/a |
PS Ratio | 4.73 |
PB Ratio | 0.30 |
P/TBV Ratio | 0.30 |
P/FCF Ratio | 10.19 |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 2.09, with an EV/FCF ratio of 1.73.
EV / Earnings | 1.48 |
EV / Sales | 0.80 |
EV / EBITDA | 2.09 |
EV / EBIT | 2.63 |
EV / FCF | 1.73 |
Financial Position
The company has a current ratio of 19.69, with a Debt / Equity ratio of 0.00.
Current Ratio | 19.69 |
Quick Ratio | 18.20 |
Debt / Equity | 0.00 |
Debt / EBITDA | 0.19 |
Debt / FCF | 0.08 |
Interest Coverage | 52.31 |
Financial Efficiency
Return on equity (ROE) is 3.46% and return on invested capital (ROIC) is 0.48%.
Return on Equity (ROE) | 3.46% |
Return on Assets (ROA) | 0.46% |
Return on Invested Capital (ROIC) | 0.48% |
Return on Capital Employed (ROCE) | 0.73% |
Revenue Per Employee | 344.90M |
Profits Per Employee | 185.44M |
Employee Count | 298 |
Asset Turnover | 0.06 |
Inventory Turnover | 1.86 |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +9.32% in the last 52 weeks. The beta is 1.03, so BioNote's price volatility has been similar to the market average.
Beta (5Y) | 1.03 |
52-Week Price Change | +9.32% |
50-Day Moving Average | 4,837.70 |
200-Day Moving Average | 4,614.75 |
Relative Strength Index (RSI) | 42.55 |
Average Volume (20 Days) | 70,733 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, BioNote had revenue of KRW 102.78 billion and earned 55.26 billion in profits. Earnings per share was 542.00.
Revenue | 102.78B |
Gross Profit | 50.97B |
Operating Income | 12.22B |
Pretax Income | 73.33B |
Net Income | 55.26B |
EBITDA | 20.40B |
EBIT | 12.22B |
Earnings Per Share (EPS) | 542.00 |
Balance Sheet
The company has 405.42 billion in cash and 3.93 billion in debt, giving a net cash position of 401.49 billion or 3,960.93 per share.
Cash & Cash Equivalents | 405.42B |
Total Debt | 3.93B |
Net Cash | 401.49B |
Net Cash Per Share | 3,960.93 |
Equity (Book Value) | 1.64T |
Book Value Per Share | 16,137.75 |
Working Capital | 442.04B |
Cash Flow
In the last 12 months, operating cash flow was 57.92 billion and capital expenditures -10.46 billion, giving a free cash flow of 47.45 billion.
Operating Cash Flow | 57.92B |
Capital Expenditures | -10.46B |
Free Cash Flow | 47.45B |
FCF Per Share | 468.17 |
Margins
Gross margin is 49.59%, with operating and profit margins of 11.89% and 53.77%.
Gross Margin | 49.59% |
Operating Margin | 11.89% |
Pretax Margin | 71.34% |
Profit Margin | 53.77% |
EBITDA Margin | 19.85% |
EBIT Margin | 11.89% |
FCF Margin | 46.17% |
Dividends & Yields
This stock pays an annual dividend of 200.00, which amounts to a dividend yield of 4.19%.
Dividend Per Share | 200.00 |
Dividend Yield | 4.19% |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | 36.94% |
Buyback Yield | 0.01% |
Shareholder Yield | 4.21% |
Earnings Yield | 11.43% |
FCF Yield | 9.81% |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
BioNote has an Altman Z-Score of 5.99.
Altman Z-Score | 5.99 |
Piotroski F-Score | n/a |